German Rebate Contracts Under Threat From Legislation Promoting Patient Choice
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposals designed to expand patient choice over which medicines they take risk undermining Germany's discount contract system, thereby increasing drug costs, the country's largest health insurer, AOK, says.